Try Alerts Free   |   Login
Health Care › Services-Home Health Care Services

LHCG Price Correlated With Financials For LHC

Free historical financial statements for LHC Group Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 43 quarters since 2012. Compare with LHCG stock chart to see long term trends.

LHCG Stock Compared to Quarterly

LHCG Income Statement

Revenue, Net:576913000
Revenue Per Share:18.5903
Cost of Goods & Services Sold:347772000
Gross Profit:229141000
Selling, General & Admin Expense:189051000
Operating Income:38031000
Income Taxes:6966000
Net Income:22012000
Earnings Per Share, Basic:0.57
Shares Outstanding, Basic Avg:31033002

LHCG Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:5760000
Change in Accounts Receiveable:6370000
Net Cash from Operations:12326000
Net Cash from Operations Per Share:0.3972
Repurchases/Buybacks Common Stock:0
Net Cash from Financing Activities:-26018000
Property, Plant & Equipment Purchases:2936000
Net Cash from Investing Activities:-3186000
Net Change in Cash & Equivalents:-16878000

LHCG Balance Sheet

Cash and Cash Equivalents:10522000
Accounts Receivable, Net:331524000
Total Current Assets:440381000
Property, Plant & Equipment, Net:153806000
Total Assets:2914154000
Total Short-Term Liabilities:303021000
Total Liabilities:1211662000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
4,448,196 sh
-124,506 sh
-3%
$727,991
$15,840
Vanguard Group Inc
2,872,377 sh
2,476 sh
0%
$470,093
$23,134
Alpine Associates Management Inc.
996,970 sh
169,170 sh
20%
$163,164
$34,242
State Street Corp
979,322 sh
14,729 sh
2%
$160,276
$10,050
Magnetar Financial LLC
647,493 sh
-223,026 sh
-26%
$105,969
-$29,606
Morgan Stanley
603,464 sh
-39,994 sh
-6%
$98,762
-$1,450
Geode Capital Management, LLC
548,823 sh
5,418 sh
1%
$89,820
$5,191
Westchester Capital Management, LLC
534,018 sh
 
$83,167
Dimensional Fund Advisors LP
530,724 sh
-1,644 sh
0%
$86,860
$3,951
JPMorgan Chase & Co
451,626 sh
111,443 sh
33%
$73,914
$20,934
Arp Americas Lp
435,921 sh
-180,249 sh
-29%
$71,343
-$24,619
Bank Of America Corp /De/
409,969 sh
294,831 sh
256%
$67,096
$49,164
Millennium Management LLC
409,847 sh
-748 sh
0%
$67,076
$3,130
Goldman Sachs Group Inc
400,440 sh
57,969 sh
17%
$65,536
$12,200
Northern Trust Corp
389,127 sh
-40,764 sh
-9%
$63,685
-$8,794
Sand Grove Capital Management Llp
381,199 sh
86,125 sh
29%
$62,387
$16,432
Charles Schwab Investment Management Inc
377,852 sh
11,395 sh
3%
$61,840
$4,767
Pentwater Capital Management Lp
365,000 sh
35,000 sh
11%
$59,736
$8,342
Alliancebernstein L.P.
359,935 sh
12,488 sh
4%
$58,907
$4,796
Cnh Partners LLC
333,836 sh
18,889 sh
6%
$54,636
$5,832
COMPANY PROFILE
Organization LHC Group, Inc. (the “Company”) is a health care provider specializing in the post-acute continuum of care. The Company provides services through five segments: home health, hospice, home and community-based services, facility-based services, the latter primarily through long-term acute care hospitals ("LTACHs"), and healthcare innovations ("HCI").

As of December 31, 2021, the Company, through its wholly and majority-owned subsidiaries, equity joint ventures, controlled affiliates, and management agreements, operated 970 service providers in 37 states within the continental United States and the District of Columbia.

COVID-19 Update

SARS-CoV-2 ("COVID-19") continues to spread and various responses related to stay-at-home restrictions, travel restrictions, and other public health and safety measures continue to evolve. We communicate with our clinicians and other employees all updated policies and procedures as we monitor changes related to the pandemic. Policies and procedures related to social distancing and cleaning procedures remain in place as the safety of our patients and employees are vital. The effects of COVID-19 continue to materially impact our business. As a result, operating results for the twelve months ended December 31, 2021 may not be directly comparable to operating results for the twelve months ended December 31, 2020.

CARES Act

In response to COVID-19, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") on March 27, 2020. The CARES Act was passed to provide $100 billion of Provider Relief Funds for distribution to eligible providers who provided diagnoses, testing, or care for individuals with a possible or actual case of COVID-19, specifically to reimburse providers for health care related expenses related to the prevention of the spread of COVID-19, preparations for treating cases of COVID-19 positive patients, and for lost revenues attributable to COVID-19. The CARES Act also provided financial hardship relief to Medicare providers impacted by the COVID-19 pandemic in order to provide necessary funds when there is a disruption in Medicare claims submission and/or Medicare claims processing by distributing funds through the Accelerated and Advanced Payments Program ("CAAP").

In addition, the CARES Act suspended the 2% sequestration payment adjustments on Medicare patient claims with dates of service from May 1 through December 31, 2020, suspended the application of site-neutral payment for LTACH admissions that were admitted during the Public Health Emergency ("PHE"), and delayed payment of the employer portion of social security tax. On April 14, 2021, Congress passed legislation to continue the suspension of the 2% sequestration payment adjustments on Medicare patient claims with dates of service through December 31, 2021. On December 10, 2021, the Protecting Medicare and American Farmers from Sequester Cuts Act legislation passed, which will continue the suspension of the sequestration payment adjustments for Medicare patient claims with dates of service through March 31, 2022. Medicare patient claims with dates of service between April 1 through June 30, 2022 will have 1% sequestration adjustment and Medicare patient claims with dates of service beginning July 1, 2022 will have 2% sequestration adjustment. On January 14, 2022, the U.S. Department of Health and Human Services extended the PHE until April 15, 2022.

Provider Relief Fund

During the twelve months ended December 31, 2020, the Company received $93.3 million in payments from the Provider Relief Fund, which was recorded as a short-term liability in government stimulus advance in our consolidated balance sheets. The Company returned all Provider Relief Funds received of $93.3 million to the government during the twelve months ended December 31, 2021.

CAAP

During the twelve months ended December 31, 2020, the Company received $318.0 million of accelerated payments u

Data imported from LHC Group Inc. SEC filings. Check original filings before making any investment decision.